07/ 29/ 2026
Loncom Pharma’s Ertugliflozin Tablets Approved in China
Loncom Pharma develops Ertugliflozin Tablets, showcasing integrated API, formulation, manufacturing, and generic drug expertise.
07/ 27/ 2026
FDA Updates ANDA Bioequivalence Guidance Aligning with ICH M13A: New Opportunities for Global Generic Drug Development
Loncom Pharma analyzes FDA ANDA bioequivalence updates and supports global generic drug development strategies.
07/ 24/ 2026
Loncom Pharma Strengthens GMP Compliance Culture Through the 10th GMP Knowledge Competition
Loncom Pharma strengthens GMP excellence through its 10th knowledge competition, enhancing quality culture and pharmaceutical manufacturing standards.
